Matches in SemOpenAlex for { <https://semopenalex.org/work/W2318555094> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2318555094 endingPage "93" @default.
- W2318555094 startingPage "87" @default.
- W2318555094 abstract "Abstract Bevacizumab, monoclonal antibody targeting vascular endothelial growth factor, is effective in different tumors, including colorectal carcinoma, non-small cell lung cancer, renal cell carcinoma and breast cancer. Increased serum or urinary concentrations of neopterin, an indicator of systemic immune response, have been described in patients with tumors of different primary locations, and further increase has been observed during anticancer therapy. An increase of urinary neopterin has been described after administration of cytokines, cytotoxic chemotherapy, or external beam radiation, but less is known about the effects of targeted agents on systemic immune response. We have studied serum homocysteine, C-reactive protein, α-tocopherol and retinol, and urinary neopterin in patients with metastatic breast cancer treated with bevacizumab, taxane and carboplatin. Homocysteine and C-reactive protein were determined immunochemically. α-tocopherol, retinol and urinary neopterin were determined by high performance liquid chromatography. Homocysteine, C-reactive protein and urinary neopterin decreased, while retinol and α-tocopherol increased during the therapy. In conclusion, the treatment of patients with metastatic breast cancer with bevacizumab, taxane and carboplatin resulted in the suppression of systemic inflammatory and immune response. The suppression of systemic inflammatory and immune response was associated with an increase in serum vitamin concentrations." @default.
- W2318555094 created "2016-06-24" @default.
- W2318555094 creator A5009523282 @default.
- W2318555094 creator A5012166679 @default.
- W2318555094 creator A5020329469 @default.
- W2318555094 creator A5021441981 @default.
- W2318555094 creator A5030005750 @default.
- W2318555094 creator A5033397980 @default.
- W2318555094 creator A5038039431 @default.
- W2318555094 creator A5064425904 @default.
- W2318555094 creator A5068334360 @default.
- W2318555094 creator A5070117448 @default.
- W2318555094 creator A5089948892 @default.
- W2318555094 date "2010-02-01" @default.
- W2318555094 modified "2023-09-27" @default.
- W2318555094 title "Urinary Neopterin, Serum Retinol, α-tocopherol and Homocysteine in Breast Cancer Patients During Treatment with Bevacizumab and Chemotherapy" @default.
- W2318555094 doi "https://doi.org/10.1515/pteridines.2010.21.1.87" @default.
- W2318555094 hasPublicationYear "2010" @default.
- W2318555094 type Work @default.
- W2318555094 sameAs 2318555094 @default.
- W2318555094 citedByCount "3" @default.
- W2318555094 countsByYear W23185550942012 @default.
- W2318555094 countsByYear W23185550942016 @default.
- W2318555094 crossrefType "journal-article" @default.
- W2318555094 hasAuthorship W2318555094A5009523282 @default.
- W2318555094 hasAuthorship W2318555094A5012166679 @default.
- W2318555094 hasAuthorship W2318555094A5020329469 @default.
- W2318555094 hasAuthorship W2318555094A5021441981 @default.
- W2318555094 hasAuthorship W2318555094A5030005750 @default.
- W2318555094 hasAuthorship W2318555094A5033397980 @default.
- W2318555094 hasAuthorship W2318555094A5038039431 @default.
- W2318555094 hasAuthorship W2318555094A5064425904 @default.
- W2318555094 hasAuthorship W2318555094A5068334360 @default.
- W2318555094 hasAuthorship W2318555094A5070117448 @default.
- W2318555094 hasAuthorship W2318555094A5089948892 @default.
- W2318555094 hasBestOaLocation W23185550941 @default.
- W2318555094 hasConcept C121608353 @default.
- W2318555094 hasConcept C126322002 @default.
- W2318555094 hasConcept C203014093 @default.
- W2318555094 hasConcept C2776603314 @default.
- W2318555094 hasConcept C2776694085 @default.
- W2318555094 hasConcept C2777802072 @default.
- W2318555094 hasConcept C530470458 @default.
- W2318555094 hasConcept C71924100 @default.
- W2318555094 hasConcept C77411442 @default.
- W2318555094 hasConceptScore W2318555094C121608353 @default.
- W2318555094 hasConceptScore W2318555094C126322002 @default.
- W2318555094 hasConceptScore W2318555094C203014093 @default.
- W2318555094 hasConceptScore W2318555094C2776603314 @default.
- W2318555094 hasConceptScore W2318555094C2776694085 @default.
- W2318555094 hasConceptScore W2318555094C2777802072 @default.
- W2318555094 hasConceptScore W2318555094C530470458 @default.
- W2318555094 hasConceptScore W2318555094C71924100 @default.
- W2318555094 hasConceptScore W2318555094C77411442 @default.
- W2318555094 hasIssue "1" @default.
- W2318555094 hasLocation W23185550941 @default.
- W2318555094 hasOpenAccess W2318555094 @default.
- W2318555094 hasPrimaryLocation W23185550941 @default.
- W2318555094 hasRelatedWork W2039925094 @default.
- W2318555094 hasRelatedWork W2065192854 @default.
- W2318555094 hasRelatedWork W2091319309 @default.
- W2318555094 hasRelatedWork W2119336542 @default.
- W2318555094 hasRelatedWork W2317474597 @default.
- W2318555094 hasRelatedWork W2586319552 @default.
- W2318555094 hasRelatedWork W4238549103 @default.
- W2318555094 hasRelatedWork W4288392727 @default.
- W2318555094 hasRelatedWork W4380186280 @default.
- W2318555094 hasRelatedWork W3032782808 @default.
- W2318555094 hasVolume "21" @default.
- W2318555094 isParatext "false" @default.
- W2318555094 isRetracted "false" @default.
- W2318555094 magId "2318555094" @default.
- W2318555094 workType "article" @default.